Fibroblast activation protein inhibitor
AssigneeBoomray Pharmaceuticals Co., Ltd.
InventorsZhibo Liu, Mengxin Xu, Junyi Chen
Life of this patent
Estimating the term…
Abstract
Provided are a compound as represented by general formula (I) or a pharmaceutically acceptable salt, a stereoisomer or a solvate thereof, wherein C is a chelator unit; AB is an albumin binding unit; and FAPI is a fibroblast activation protein inhibitor unit. Also provided are a chelate of the above-mentioned compound and a radioactive nuclide, a pharmaceutical composition and the use thereof as a fibroblast activation protein inhibitor for the diagnosis and treatment of diseases. C-AB-FAPI (1)
Claims13
A compound or a pharmaceutically acceptable salt, a stereoisomer or a solvate thereof, wherein the compound is
Dependencies are inferred from the claim text.